Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: Immediate results and six-month follow-up of the multicenter AngioJet® registry
✍ Scribed by Silva, Jose A. ;Ramee, Stephen R. ;Collins, Tyrone J. ;Jenkins, J. Stephen ;Lansky, Alexandra J. ;Ansel, Gary M. ;Dolmatch, Bart L. ;Glickman, Mark H. ;Stainken, Brian ;Ramee, Emily ;White, Christopher J.
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 178 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0098-6569
No coin nor oath required. For personal study only.
✦ Synopsis
Peripheral AngioJet Study AngioJet Investigators
We tested the efficacy of rheolytic thrombectomy in treating 21 patients (mean age 68 ؎ 12 years; 66% male) and 22 vessels (limbs) who presented to the hospital within 2 weeks of the development of limb-threatening ischemia. Fifty-two percent had contraindications to use thrombolytics, and 57% had severe comorbidities. All of the vessels were occluded with thrombus on the initial angiogram. Procedural success was achieved in 20 limbs (91%). Three patients expired in the hospital, and one expired at follow-up due to nonvascular causes. Acute limb salvage was achieved in 18 of 19 limbs (95%) in the 18 survivors, and 6-month limb salvage was achieved in 16 of 18 limbs (89%) in the 17 survivors. Rheolytic thrombectomy is effective in restoring immediate blood flow in acute limb-threatening ischemia, especially in high-risk surgical patients or patients with contraindications to thrombolytic therapy.